Systematic Review and Meta-Analysis of Real-World Studies Evaluating Rivaroxaban for Cancer-Associated Venous Thrombosis
Author:
Affiliation:
1. University of Connecticut School of Pharmacy; Storrs Connecticut
2. Hartford Hospital Evidence-Based Practice Center; Hartford Connecticut
Publisher
Wiley
Subject
Pharmacology (medical)
Reference31 articles.
1. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology;Winter;Hematol Oncol,2006
2. Risk factors for deep vein thrombosis and pulmonary embolism;Heit;Arch Intern Med,2000
3. Malignancies, prothrombotic mutations, and the risk of venous thrombosis;Blom;JAMA,2005
4. The coagulopathy of cancer;Falanga;Curr Opin Hematol,2014
5. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of direct oral anticoagulants and low molecular weight heparin in venous thromboembolism associated with cancer: real-world evidence in Argentina;Expert Review of Hematology;2023-11-16
2. Arguments for Using Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism;Healthcare;2021-09-28
3. Rivaroxaban for cancer-associated venous thromboembolism;Science Progress;2021-04
4. Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre;Thrombosis Journal;2020-05-24
5. Direct oral anticoagulants in patients with cancer;American Journal of Health-System Pharmacy;2019-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3